Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

SELL
$238.39 - $265.32 $253,646 - $282,300
-1,064 Reduced 35.99%
1,892 $499,000
Q1 2023

May 15, 2023

SELL
$229.71 - $259.35 $8.31 Million - $9.39 Million
-36,192 Reduced 92.45%
2,956 $731,000
Q4 2022

Feb 14, 2023

BUY
$218.29 - $256.91 $7.79 Million - $9.17 Million
35,676 Added 1027.53%
39,148 $9.96 Million
Q3 2022

Nov 14, 2022

BUY
$51.03 - $264.23 $49,754 - $257,624
975 Added 39.05%
3,472 $603,000
Q2 2022

Aug 15, 2022

SELL
$234.74 - $275.42 $7.19 Million - $8.43 Million
-30,620 Reduced 92.46%
2,497 $607,000
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $712,159 - $790,613
2,923 Added 9.68%
33,117 $8.81 Million
Q4 2021

Feb 14, 2022

BUY
$230.08 - $250.94 $1.53 Million - $1.66 Million
6,634 Added 28.16%
30,194 $7.59 Million
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $1.61 Million - $1.77 Million
6,905 Added 41.46%
23,560 $5.79 Million
Q2 2021

Aug 13, 2021

BUY
$232.65 - $254.58 $170,765 - $186,861
734 Added 4.61%
16,655 $4.05 Million
Q1 2021

May 14, 2021

BUY
$232.09 - $256.88 $2.63 Million - $2.91 Million
11,336 Added 247.24%
15,921 $3.87 Million
Q4 2020

Feb 08, 2021

BUY
$221.92 - $245.94 $172,431 - $191,095
777 Added 20.4%
4,585 $1.15 Million
Q3 2020

Nov 12, 2020

SELL
$215.77 - $276.76 $66,241 - $84,965
-307 Reduced 7.46%
3,808 $886,000
Q2 2020

Jul 17, 2020

BUY
$219.9 - $263.41 $442,878 - $530,507
2,014 Added 95.86%
4,115 $985,000
Q1 2020

May 12, 2020

BUY
$195.69 - $279.01 $105,868 - $150,944
541 Added 34.68%
2,101 $483,000
Q4 2019

Feb 11, 2020

SELL
$236.45 - $266.82 $142,815 - $161,159
-604 Reduced 27.91%
1,560 $424,000
Q3 2019

Nov 13, 2019

SELL
$230.58 - $256.08 $27,439 - $30,473
-119 Reduced 5.21%
2,164 $547,000
Q2 2019

Aug 12, 2019

BUY
$217.4 - $246.08 $16,305 - $18,456
75 Added 3.4%
2,283 $576,000
Q1 2019

May 08, 2019

SELL
$206.05 - $248.17 $110,236 - $132,770
-535 Reduced 19.5%
2,208 $551,000
Q4 2018

Feb 14, 2019

BUY
$204.73 - $257.93 $90,081 - $113,489
440 Added 19.11%
2,743 $618,000
Q3 2018

Nov 14, 2018

SELL
$233.07 - $256.0 $70,620 - $77,568
-303 Reduced 11.63%
2,303 $601,000
Q2 2018

Aug 14, 2018

SELL
$208.1 - $233.85 $81,367 - $91,435
-391 Reduced 13.05%
2,606 $624,000
Q1 2018

May 14, 2018

SELL
$205.46 - $240.27 $316,202 - $369,775
-1,539 Reduced 33.93%
2,997 $689,000
Q4 2017

Feb 15, 2018

BUY
$189.0 - $222.64 $230,202 - $271,175
1,218 Added 36.71%
4,536 $971,000
Q3 2017

Nov 14, 2017

BUY
$186.89 - $198.9 $620,101 - $659,950
3,318
3,318 $650,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $64.8B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Vident Investment Advisory, LLC Portfolio

Follow Vident Investment Advisory, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vident Investment Advisory, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Vident Investment Advisory, LLC with notifications on news.